Our integration of in silico resources confirmed the overexpression of RAE1 in patients with breast cancer, in accordance with previous reports that demonstrated RAE1 copy number variation (CNV) and gene expression abnormalities14, 15. The gene discussed is RAE1; the disease is breast cancer.